Puromycin . Dihydrochloride Z-DNA-binding Protein 1; Tumor Stroma and Activated Macrophage Protein DLM-1; DNA-dependent Activator of IFN-regulatory Factors; DAI FLT3 and c-Kit

FLT3 and c-Kit

AG-CN2-0020) for 30 min

These relatively effective methods require ultracentrifugation and a large amount of starting material

ODN 1585 or 2216) leading to antigen presenting cell (APC) maturation

and elicits proportionally less toxicity by lowering the expansion of T-regulatory cells and reducing pulmonary oedema

Puromycin . Dihydrochloride Z-DNA-binding Protein 1; Tumor Stroma and Activated Macrophage Protein DLM-1; DNA-dependent Activator of IFN-regulatory Factors; DAI FLT3 and c-KitAminonucleoside antibiotic. Protein synthesis inhibitor. Disrupts peptide transfer on ribosomes (acting as an acyl tRNA analog) causing premature chain termination during translation. Translational inhibitor in prokaryotic and eukaryotic cells in both in vitro and in vivo systems. Inhibits the transport of proteins into the mitochondria in vitro. Reversible inhibitor of dipeptidyl peptidase II (serine peptidase) and cytosol alanyl aminopeptidase